Elicio Therapeutics (ELTX) Prepaid Assets (2020 - 2026)
Elicio Therapeutics' (ELTX) quarterly Prepaid Assets came in at $1.3 million in Q1 2026, down 34.14% YoY from $1.9 million in Q1 2025, and up 67.38% on a QoQ basis from $748000.0 in Q4 2025.
Elicio Therapeutics (ELTX) Prepaid Assets (2020 - 2026) Analysis & Trends
Elicio Therapeutics (ELTX) has 7 years of Prepaid Assets data on file, last reported at $1.3 million in Q1 2026.
- Quarterly Prepaid Assets fell 34.14% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 34.14% YoY) and the FY2025 annual result came in at $748000.0, down 60.57% from the prior year.
- Prepaid Assets rose to $1.3 million in Q1 2026, from $748000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.5 million in Q2 2023 to a low of $405000.0 in Q1 2023.
- A 5-year average of $1.8 million and a median of $1.6 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets sank 84.88% — and 2023, when it soared 881.21%.
- Tracing ELTX's Prepaid Assets over 5 years: stood at $2.9 million in 2022, then declined by 6.44% to $2.7 million in 2023, then tumbled by 30.56% to $1.9 million in 2024, then sank by 60.57% to $748000.0 in 2025, then jumped by 67.38% to $1.3 million in 2026.
- The last three Prepaid Assets figures came in at $1.3 million (Q1 2026), $748000.0 (Q4 2025), and $854000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Elicio Therapeutics | 58.41 Mn | 34.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.01 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 748,000.00 |
| Sep 30, 2025 | 854,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Mar 31, 2025 | 1.90 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 3.31 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 2.73 Mn |
| Sep 30, 2023 | 3.42 Mn |
| Jun 30, 2023 | 4.54 Mn |
| Mar 31, 2023 | 405,000.00 |
| Dec 31, 2022 | 2.92 Mn |
| Sep 30, 2022 | 1.54 Mn |
| Jun 30, 2022 | 463,000.00 |
| Mar 31, 2022 | 460,000.00 |
| Dec 31, 2021 | 1.69 Mn |
| Sep 30, 2021 | 549,000.00 |